
Dr. Luke
Nordquist
Scientific Advisor

CEO at Urology Cancer Center and XCancer Research
Luke Nordquist, MD, FACP is the CEO of the XCancer Research Network and founded the Urology Cancer Center & GU Research Network. XCancer enables, oversees, and helps support clinical trials in community Oncology centers across the US. XCancer has worked with over 40 community cancer centers — the network has supported the approval of several novel Oncology therapeutics. Dr. Nordquist has become a global Oncology KOL through his leading role in groundbreaking clinical trials from Phase I-IV. He has been the principal investigator on several hundred urologic cancer studies including several first-in-world treatments.